<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR89421-0114 </DOCNO><DOCID>fr.4-21-89.f2.A1113</DOCID><TEXT><FTAG tagnum="4701"/><ITAG tagnum="90"><T4>Federal Register</T4> / Vol. 54, No. 76 / Friday, 1989 / Notices<ITAG tagnum="52">DEPARTMENT OF HEALTH AND HUMAN SERVICES</ITAG><ITAG tagnum="18">Food and Drug Administration</ITAG><ITAG tagnum="41">[Docket No. 84N-0102]</ITAG><ITAG tagnum="52">Cumulative List of Orphan-Drug and Biological Designations</ITAG><ITAG tagnum="10"><T2>AGENCY: </T2>Food and Drug Administration, HHS.</ITAG><ITAG tagnum="10"><T2>ACTION: </T2>Notice.</ITAG><ITAG tagnum="10"><T2>SUMMARY: </T2>The Food and Drug Administration (FDA) previously announcedthe availability of a list, which is brought up-to-date quarterly, identifyingthe drugs and biologicals granted orphan-drug designation pursuant to section526 of the Federal Food, Drug, and Cosmetic Act (54 FR 7100; February 16,1989). The printing and format errors which occurred in the list couldnot adequately be amended by a correction notice. Therefore, by this notice,FDA is announcing a revised publication of the notice of availability ofthe cumulative list of designated orphan drugs and biological productsas of December 31, 1988. This notice supersedes the notice of February16, 1989.</ITAG><ITAG tagnum="10"><T2>ADDRESS: </T2>Copies of the revised publication of the list of currentorphan-drug designations and of any future lists are or will be availablefrom the Dockets Management Branch (HFA-305), Food and Drug Administration,Rm. 4-62, 5600 Fishers Lane, Rockville, MD 20857.</ITAG><ITAG tagnum="10"><T2>FOR FURTHER INFORMATION CONTACT:</T2>Aleta M. Sindelar, Office of OrphanProducts Development (HF-35), Food and Drug Administration, 5600 FishersLane, Rockville, MD 20857, 301-443-4903.</ITAG><ITAG tagnum="10"><T2>SUPPLEMENTARY INFORMATION: </T2>FDA's Office of Orphan Products Developmentreviews and takes final action on applications submitted by sponsors seekingorphan-drug designation under section 526 of the Federal Food, Drug, andCosmetic Act (the act) (21 U.S.C. 360bb). In accordance with this sectionof the act, which requires public notification of designations, FDA maintainsa list of designated orphan drugs and biological products. This list ismade current on a quarterly basis and is available upon request from FDA'sDockets Management Branch (address above). Those requesting a copy of thelist should specify the docket number found in brackets in the headingof this document. At the end of each calendar year, the agency intendsto publish in the <T4>Federal Register</T4> an up-to-date cumulative list of designated orphandrugs and biological products including the names of designated compounds,the specific disease/condition for which the compounds are designated,and the sponsors' names and addresses. The cumulative list of compoundsreceiving orphan-drug designation through 1987 was published in the <T4>Federal Register</T4> of January 29, 1988 (53 FR 2680).The list that is the subject of this notice consists of designated orphandrugs and biological products through December 31, 1988, and, therefore,brings the January 29, 1988, publication up to date. This list was initiallyprinted in the <T4>Federal Register</T4> notice of February 16, 1989 (54 FR 7100). However,typographical errors as well as format revisions in the list occurred atthe time of publication. These errors could not adequately be amended bya correction notice. This revised publication of designated orphan drugsthrough December 31, 1988, will supersede the February 16, 1989, notice.The orphan-drug designation of a drug or biological product applies onlyto the sponsor who requested the designation. Each sponsor interested indeveloping an orphan drug or biological product must apply for orphan-drugdesignation to obtain exclusive marketing rights. Any request for designationis required to be received by FDA before the submission of a marketingapplication for the proposed indication for which designation is requested.(See 53 FR 47577; November 23, 1988.) Copies of the interim guidelinesfor use in preparing an application for orphan-drug designation may beobtained from the Office of Orphan Products Development (HF-35) (contactidentified above).The names used in this notice for the drug and biological products thathave not been approved/licensed for marketing may not be the established/propernames approved by FDA for these products if they are eventually approved/licensedfor marketing. Because these products are investigational, some may nothave been reviewed for purposes of assigning the most appropriate establishedproper name.<ITAG tagnum="21">Dated: March 15, 1989.</ITAG><ITAG tagnum="6">Alan L. Hoeting,</ITAG><ITAG tagnum="4">Acting Associate Commissioner for Regulatory Affairs.</ITAG> <ITAG tagnum="110"><C>3,L2(,,0),p8,8/9,i1,s75,r75,r75</C><T4>Orphan Drug and Biological Designations Through </T4>1988<ITAG tagnum="96">[Approved for Marketings*]</ITAG><ITAG tagnum="96">[Exclusive Approval**]</ITAG><H1>Biological Designations</H1><H2>Name of biological</H2><H2>Designated use</H2><H2>Sponsor's name and address</H2><ITAG tagnum="1"><T3>Generic_alpha-1-anti-trypsin (recombinant DNA origin)</T3><P/><T3/>Trade_Not established<D>Supplementation therapy for alpha-1 antitrypsin deficiency in the ZZphenotype population</D><D>Cooper Biomedical, 3145 Porter Drive, Palo Alto, CA 94304.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_alpha-1-proteinase inhibitor (Alpha-1 PI)<P/><T3>Trade</T3>_Prolastin */**<D>Replacement therapy in the Alpha 1 PI congenital deficiency state </D><D>Cutter Laboratories, P.O. Box 1986, Berkeley, CA 94701</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_anti-J5mAb<P/><T3>Trade</T3>_Not established<D>Treatment of patients with gram-negative bacteremia which has progressedto endotoxin shock</D><D>Centocor, Inc., 244 Great Valley, Malvern, PA 19355.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_antimelanoma antibody XMMME-01-RTA<P/><T3>Trade</T3>_Same as generic<D>Treatment of Stage III melanoma not amenable to surgical resection</D><D>XOMA Corporation, 3516 Sacramento St., San Francisco, CA 94118.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_anti-TAP-72 immunotoxin<P/><T3>Trade</T3>_XOMAZYME-791<D>Treatment of metastatic colorectal adenocarcinoma</D><D>XOMA Corporation, 2910 Seventh Street, Berkeley, CA 94710.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_antithrombin III(AT-III) <P/><T3>Trade</T3>_Not established<D>Replacement therapy in congenital deficiency of AT-III for preventionand treatment of thrombosis and pulmonary emboli</D><D>Cutter Laboratories, P.O. Box 1986, Berkeley, CA 94701.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_antithrombin III concentrate I.V.<P/><T3>Trade</T3>_Kybernin<D>Prophylaxis and treatment of thromboembolic episodes in patients withgenetic AT-III deficiency</D><D>Hoeschst-Roussell, Route 202-206 North, Somerville, NJ 08876.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_antithrombin III (human) <P/><T3>Trade</T3>_Antithrombin<D>Hereditary AT-III deficiency </D><D>Kabi Vitrum, Inc., 1311 Harbor Bay Pkwy., Alameda, CA 94501</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_antithrombin III (human)<P/><T3>Trade</T3>_Antithrombin III (human)<D>Preventing or arresting episodes of thrombosis in patients with congenitalantithrombin III deficiency and/or to prevent the occurrence of thrombosisin patients with antithrombin III deficiency who have undergone traumaor who are about to undergo surgery or parturition </D><D>American National Red Cross, National HDQ, 17th and E St., NW., Washington,DC 20006</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_benzylpenicillin, benzylpenicilloic acid, and benzylpenilloicacid<P/><T3>Trade</T3>_Pre-Pen/MDM<D>Assessing the risk of administrating penicillin when it is the preferreddrug of choice in adult patients who have previously received penicillinand have a history of clinical hypersensitivity</D><D>Kremers-Urban Co., P.O. Box 2038, Milwaukee, WI 53201.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_botulinum A toxin<P/> <T3>Trade</T3>_Oculinum<D>Treatment of strabismus</D><P>Treatment of blepharospasm</P><D>Alan B. Scott, M.D., 2232 Webster Street, San Francisco, CA 94115.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_botulinum toxin<P/><T3>Trade</T3>_Ortholinum<D>Treatment of spasmodic torticollis</D><D>Alan B. Scott, M.D., 2232 Webster Street, San Francsco, CA 94115.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_CD5-T Lymphocyte Immunotoxin<P/><T3>Trade</T3>_XOMAZYME-H65<D>For ex-vivo treatment to eliminate mature T cells from potential bonemarrow grafts</D><P>For in-vivo treatment of bone marrow recipients to prevent graft rejectionand graft vs host disease (GVHD)</P><P>Treatment of graft vs host disease (GVHD) and/or rejection in patientswho have received bone marrow transplants</P><D>XOMA Corporation, 2910 Seventh Street, Berkeley, CA 94710.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cytomegalovirus Immune Globulin (Human)<P/><T3>Trade</T3>_Not established<D>Prevention or attenuation of primary cytomegalovirus disease in immunosuppressedrecipients of organ transplants</D><D>Massachusetts Public Health Biologic Labs, 305 South Street, JamaicaPlain, MA 02130.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_digoxin Immune Fab (Ovine)<P/><T3>Trade</T3>_Digidote<D>Life-threatening acute cardiac glycoside intoxication manifested conductiondisorders, ectopic ventricular activity and (in some cases) hyperkalemia</D><D>Boehringer Mannheim, 1301 Piccard Drive, Rockville, MD 20850.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_digoxin Immune Fab (Ovine)<P/><T3/>Trade_Digibind*/**<D>Treatment of potentially life-threatening digitalis intoxication inpatients who are refractory to management by conventional therapy</D><D>Burroughs-Wellcome, 3030 Cornwallis Road, Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erwinia l-asparaginase<P/>Trade_Not established<D>Treatment of acute lymphocytic leukemia (ALL)</D><D>Porton Products Ltd., 5445 Balboa Blvd., Suite 115, Encino, CA 91316.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erwinia l-asparaginase<P/><T3>Trade</T3>_Not established <D>Treatment of acute lymphocytic leukemia (ALL)</D><D>Lypho Med, Inc., 2020 Ruby Street, Melrose Park, IL 60160.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erythropoietin (recombinant-human)<P/><T3>Trade</T3>_Not established<D>Treatment of anemia associated with end stage renal disease (ESRD)</D><D>Amgen, 1900 Oak Terrace La., Thousand Oaks, CA 91320.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erythropoietin (recombinant-human)<P/><T3>Trade</T3>_Not established<D>Treatment of anemia associated with end stage renal disease (ESRD)</D><D>McDonnell Douglas, P.O. Box 516, St. Louis, MO 63166.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erythropoietin (recombinant-human)<P/><T3>Trade</T3>_Not established<D>Treatment of anemia associated with end stage renal disease (ESRD)</D><P>Treatment of anemia of prematurity in preterm infants</P><D>Ortho Pharmaceutical Corporation, Route 202, P.O. Box 300, Raritan,NJ 08869-0602.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erythropoietin (recombinant-human)<P/><T3>Trade</T3>_EPOCH<D>Treatment of anemia associated with end stage renal disease (ESRD) </D><D>Chugai Pharmaceuticals 1-9, Kyobashi 2-Chome, Chu, Tokyo 104, Japan.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_erythropoietin (recombinant-human)<P/><T3>Trade</T3>_Not established <D>Treatment of anemia associated with end stage renal disease (ESRD)</D><D>Organon Teknika, 800 Capitola Drive, Durham, NC 27713.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_factor VIIa (recombinant, DNA origin)<P/><T3>Trade</T3>_Not established<D>Treatment of patients with hemophilia A andamp; B with and without antibodiesagainst Factor VIII/IX</D><P>Treatment of patients with von Willebrand's disease</P><D>Novo Laboratories, 33 Turner Road, Danbury, CT 06810-5101.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_factor XIII<P/><T3>Trade</T3>_Fibrogammin<D>Congenital Factor XII deficiency</D><D>Hoechst-Roussel Pharmaceuticals, Route 202-206 North, Somerville, NJ08876.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_fibronectin (human plasma derived)<P/><T3>Trade</T3>_Not established<D>Treatment of non-healing corneal ulcers or epithelial defects whichhave been unresponsive to conventional therapy and the underlying causehas been eliminated</D><D>The New York Blood Center, Inc. 310 East 67 St., N.Y., N.Y. 10021.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_fibronectin (plasma derived)<P/><T3>Trade</T3>_Not established<D>Treatment of non-healing corneal ulcers or epithelial defects whichhave been unresponsive to conventional therapy and for which any infectiouscause has been eliminated</D><D>Chiron Ophthalmics, 15A Marconi, Irvine, CA 92718.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_heme arginate<P/><T3>Trade</T3>_Normosang<D>Treatment of symptomatic stage of acute porphyria</D><D>Huhtamaki Oy Pharmaceuticals, Leiras Medic, P.O. Box 415, SF-20101 Turku,Finland.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_hemin<P/><T3>Trade</T3>_Panhematin*/**<D>Amelioration of recurrent attacks of acute intermittent porphyria temporarilyrelated to the menstrual cycle in susceptible women and similar symptomswhich occur in other patients with acute intermittent porphyria, porphyriavariegata and hereditary coproporphyria</D><D>Abbott Laboratories, North Chicago, IL 60064.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_Indium In 111 antimelanoma antibody XMMME-0001-DTPA <P/><T3>Trade</T3>_Same as generic<D>Diagnostic use in imaging systemic and nodal melanoma metastases</D><D>XOMA Corporation, 3516 Sacramento St., San Francisco, CA 94118.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_interferon alfa-nl<P/><T3>Trade</T3>_Wellferon<D>Treatment of Acquired Immune Deficiency Syndrome (AIDS)-related Kaposi'sSarcoma</D><P>Treatment of Human Papillomavirus (HPV) in patients with severe resistant/recurrentrespiratory (laryngeal) papillomatosis</P><D>Burroughs Wellcome, 3030 Cornwallis Road, Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_interferon alfa-2a (recombinant)<P/><T3>Trade</T3>_Roferon-A*/**<D>Treatment of selected patients with Acquired Immune Deficiency Syndrome(AIDS)-related Kaposi's Sarcoma*/**</D><P>Treatment of metastatic renal cell carcinoma</P><D>Hoffman-LaRoche, 340 Kingsland St., Nutley, NJ 07110.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_interferon alfa-2b (recombinant)<P/><T3>Trade</T3>_Intron A*/**<D>Treatment of chronic myelogenous leukemia (CML)</D><P>Treatment of metastatic renal cell carcinoma</P><P>Treatment of selected patients with AIDS-related Kaposi's Sarcoma*/**</P><P>Treatment of ovarian carcinoma</P><P>Treatment of invasive carcinoma of the cervix</P><P>Treatment of primary malignant brain tumors</P><P>Treatment of carcinoma in situ of the urinary bladder</P><P>Treatment of human papillomavirus (HPV) in patients with recurrent respiratory(laryngeal) papillomatosis</P><P>Treatment of of acute hepatitis B</P><D>Schering Corporation, 2000 Galloping Hill Road, Kenilworth, NJ 07033.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_interferon (recombinant human, beta)<P/><T3>Trade</T3>_Betaseron<D>Treatment of Acquired Immune Deficiency Syndrome (AIDS)</D><P>Treatment of Multiple Sclerosis (MS)</P><D>Triton Biosciences, 1501 Harbor Bay Pkwy., Alameda, CA 94501.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_interferon gamma-lb<P/><T3>Trade</T3>_Not established<D>Treatment of Chronic Granulomatous Disease (CGD)</D><D>Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco,CA 94080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_interleukin-2, recombinant<P/><T3>Trade</T3>_Proleukin<D>Treatment of metastatic renal cell carcinoma</D><D>Cetus Corporation, 1400 Fifty-Third St., Emeryville, CA 94608.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_iodine I 123 murine monoclonal antibody to human alpha-fetoprotein<P/><T3>Trade</T3>_Not established<D>Detection of hepatocellular carcinoma and hepatoblastoma</D><P>Detection of alpha-fetoprotein producing germ cell tumors</P><D>Immunomedics, Inc., 5 Bruce Street, Building andplusmin;7, Newark, NJ07013.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_iodine I 123 murine monoclonal antibody to human chorionicgonadotropin (hCG)<P/><T3>Trade</T3>_Not established<D>Detection of hCG producing tumors such as germ cell and trophoblasticcell tumors</D><D>Immunomedics, Inc., 150 Mt. Bethel Rd., CN4918, Warren, NJ 07060.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_iodine I 131 Lym-1 monoclonal antibody<P/><T3>Trade</T3>_Not established<D>Treatment of B-cell lymphoma</D><D>Lederle Laboratories, Pearl River, NY 10965.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_iodine I 131 murine monoclonal antibody to human alpha-fetoprotein<P/><T3>Trade</T3>_Not established<D>Treatment of hepatocellular carcinoma and hepatoblastoma</D><P>Treatment of alpha-fetoprotein producing germ cell tumors</P><D>Immunomedics, Inc., 5 Bruce Street, Building andplusmin;7, Newark, NJ07013.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_iodine I 131 murine monoclonal antibody to human chorionicgonadotropin (hCG)<P/><T3>Trade</T3>_Not established<D>Treatment of hCG producing tumors such as germ cell and trophoblasticcell tumors</D><D>Immunomedics, Inc., 150 Mt. Bethel Rd., CN4918, Warren, NJ 07060.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_monoclonal antibodies (murine or human) recognizing B-celllymphoma idiotypes<P/><T3>Trade</T3>_Not established<D>Treatment of B-cell lymphoma</D><D>IDEC, Inc., 291 North Bernardo Ave., Mountain View, CA 94043.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_monoclonal antibody 17-1A<P/><T3>Trade</T3>_Panorex<D>Treatment of pancreatic cancer</D><D>Centocor, Inc., 244 Great Valley Pkwy., Malvern, PA 19355.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_monoclonal antiendotoxin antibody XMMENOE5<P/><T3>Trade</T3>_Same as generic<D>Treatment of patients with gram-negative sepsis which has progressedto shock</D><D>Pfizer Inc., 235 East 42nd St., New York, NY 10017.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_pentastarch<P/><T3>Trade</T3>_Pentaspan*/**<D>For use as an adjunct in leukapheresis, to improve the harvesting andincrease the yield of leukocytes by centrifugal means </D><D>DuPont Critical Care, 1600 Waukegan Rd., McGaw Park, IL 60085.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_polyribonucleotide<P/><T3>Trade</T3>_Ampligen<D>Treatment of Acquired Immunodeficiency Syndrome (AIDS)</D><D>HEM/Du Pont Immunological Products, Barley Mill Plaza, P27-2320, Wilmington,DE 19898.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_ricin (Blocked) conjugated murine monoclonal antibody(Anti-B4) to B cell (CD 19)<P/><T3>Trade</T3>_Not established<D>Treatment of B-cell leukemia and B-cell lymphoma</D><D>Immunogen, Inc., 148 Sidney St., Cambridge, MA 02139.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_serratia marcescens extract (polyribosomes)<P/><T3>Trade</T3>_ImuVert<D>Treatment of primary brain malignancies</D><D>Cell Technology, Inc., 1668 Valtec Lane, Boulder, CO 80301.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_ST1-RTA Immunotoxin (SR 44163)<P/><T3>Trade</T3>_Not established<D>Prevention of acute graft versus host disease (GVHD) in allogenic bonemarrow transplantation</D><P>Treatment of patients with B-chronic lymphocytic leukemia (CLL)</P><D>Sanofi, Inc., 101 Park Ave., New York, NY 10178.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_Technetium Tc 99m Anti-melanoma Murine Monoclonal AntibodyKit<P/><T3>Trade</T3>_Not established<D>For use in detecting, by imaging, metastases of malignant melanoma</D><D>NeoRx Corporation, 410 West Harrison, Seattle, WA 98119.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_trisaccharides Aandamp;B<P/><T3>Trade</T3>_Not established<D>Treatment of moderate to severe clinical forms of hemolytic diseaseof the newborn arising from placental transfer of antibodies against bloodgroup substances A and B</D><P>For use in ABO-incompatible solid organ transplantation including kidney,heart, liver, and pancreas</P><P>Treatment of moderate to very severe clinical forms of transfusion reactionsarising from ABO incompatible transfusion of blood, blood products andblood derivatives</P><P>For use in ABO-incompatible bone marrow transplantation (BMT)</P><D>CHEMBIOMED, Ltd., 16th Floor Campus Towers, 11145-87th Ave., Edmonton,Alberta, Canada T6G OY1.</D></ITAG></ITAG> <ITAG tagnum="110"><C>3,L2,p8,8/9,i1,s75,r75,r75</C><T4>Orphan Drug and Biological Designations Through </T4>1988<ITAG tagnum="96">[Approved for Marketings*]</ITAG><ITAG tagnum="96">[Exclusive Approval*/**]</ITAG><H1>Drug Designations</H1><H2>Name of drug</H2><H2>Designated use</H2><H2>Sponsor's name and address</H2><ITAG tagnum="1"><T3>Generic</T3>_acetylcysteine<P/><T3>Trade</T3>_Mucomyst/Mucomyst 10 IV <D>Intravenous treatment of patients presenting with moderate to severeacetaminophen overdose </D><D>Bristol-Myers U.S. Pharmaceutical, 2404 Pennsylvania Street, Evansville,IN 47721-0001.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_aconiazide<P/><T3>Trade</T3>_Not established <D>Treatment of tuberculosis </D><D>Lincoln Diagnostics, P.O. Box 1139, Decatur, IL 62525.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_allopurinol<P/><T3>Trade</T3>_Zyloprim <D>Ex-vivo preservation of cadaveric kidneys for transplantation </D><D>Burroughs Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_allopurinol riboside<P/><T3>Trade</T3>_Not established <D>Treatment of cutaneous visceral leishmaniasis</D><P>Treatment of Chagas' disease </P><D>Burroughs Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_amsacrine<P/><T3>Trade</T3>_Amsidyl <D>Treatment of patients with acute adult leukemia </D><D>Warner-Lambert Co., 201 Tabor Road, Morris Plains, NJ 07950.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_anagrelide<P/><T3>Trade</T3>_Not established <D>Treatment of polycythemia vera </D><D>Bristol-Myers Co., P.O. Box 4755, Syracuse, NY 13221-4755.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_anagrelide<P/><T3>Trade</T3>_Not established <D>Treatment of thrombocytosis in chronic myelogenous leukemia (CML)</D><P>Treatment of essential thrombocythemia (ET) </P><D>Bristol-Myers Pharmaceutical Research and Development Divison, 5 ResearchPkwy., P.O. Box 5100, Wallingford, CT 06492.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_antipyrine<P/><T3>Trade</T3>_Not established <D>Antipyrine test as an index of hepatic drug-metabolizing capacity </D><D>Upsher-Smith Laboratories, 14905 23rd Ave. North, Minneapolis, MN 55441.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_AS-101<P/><T3>Trade</T3>_Not established <D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><D>Scientific Testing, 783 Jersey Avenue, New Brunswick, NJ 08901.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_bacitracin, USP<P/><T3>Trade</T3>_Altracin <D>Antibiotic-associated pseudomembranous enterocolitis caused by toxinsAandamp;B elaborated by Clostridium difficile </D><D>A.L. Laboratories, 452 Hudson Terrace, P.O. Box 1621, Englewood Cliffs,NJ 07632.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_baclofen (intrathecial)<P/><T3>Trade</T3>_Lioresal <D>Treatment of intractable spasticity caused by spinal cord injury ormultiple sclerosis (MS) </D><D>Medtronic, Inc., 7000 Central Ave., Minneapolis, MN 55432.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_benzoate/phenylacetate<P/><T3>Trade</T3>_Ucephan*/** <D>For adjunctive therapy in the prevention and treatment of hyperammonemiain patients with urea cycle enzymopathy (UCE) due to carbamylphosphatesynthetase, ornithine, transcarbamylase, or arginosuccinate synthetasedeficiency </D><D>Kendall McGaw Laboratories, P.O. Box 25080, Santa Ana, CA 92799-5080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_bethanidine sulfate<P/><T3>Trade</T3>_Not established <D>Treatment of primary ventricular fibrillation </D><D>Medco Research, Inc., 8733 Beverly Blvd., Suite 404, Los Angeles, CA90048.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_BW B759U<P/><T3>Trade</T3>_Not established <D>Treatment of severe human cytomegalovirus infections (HCMV) in specificimmunosuppressed patient populations (e.g., bone marrow transplant recipientsand Acquired Immunodeficiency Syndrome patients) </D><D>Burroughs Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_BW 12C<P/><T3>Trade</T3>_Not established <D>Treatment of sickle cell disease crisis </D><D>Burroughs Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_caffeine<P/><T3>Trade</T3>_Not established <D>Treatment of apnea of prematurity </D><D>Pediatric Pharmaceuticals, Inc., 379 Thornall St., Edison, NJ 08837.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_calcitonin-human<P/><T3>Trade</T3>_Cibacalcin*/** <D>Treatment of symptomatic Paget's disease of bone (osteitis deformans)</D><D>Ciba-Geigy Corporation, 556 Morris Ave., Summit, NJ 07901.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_calcium acetate<P/><T3>Trade</T3>_Phos-Lo <D>Treatment of hyperphosphatemia in end stage renal disease (ESRD) </D><D>Braintree Laboratories, 60 Columbian St., P.O. Box 361, Braintree, MA02184.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_ceramide trihexosidase/alpha-galactosidase A<P/><T3>Trade</T3>_Not established <D>Treatment of Fabry's disease </D><D>Genzyme Corporation, 75 Kneeland St., Boston, MA 02111.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_chenodiol<P/><T3>Trade</T3>_Chenix*/** <D>For patients with radiolucent stones in well opacifying gallbladders,in whom elective surgery would be undertaken except for the presence ofincreased surgical risk due to systemic disease or age </D><D>Reid-Rowell, Inc., 210 Main Street West, Baudette, MN 56623-0370.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_chlorhexidine gluconate mouthrinse<P/><T3>Trade</T3>_Peridex <D>For use in the amelioration of oral mucositis associated with cytoreductivetherapy used in conditioning patients for bone marrow transplantation therapy</D><D>Procter andamp; Gamble Co., Sharon Woods Technical Ctr., HB Building,11511 Reed Hartman Hwy., Cincinnati, OH 45241.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cetiedil citrate<P/><T3>Trade</T3>_Not established <D>Treatment of sickle cell disease crisis </D><D>Medical Market Specialties, Inc., P.O. Box 150, Boonton, NJ 07005.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_clindamycin<P/><T3>Trade</T3>_Cleocin <D>Treatment of Pneumocystis carinii pneumonia (PCP) associated with theAcquired Immunodeficiency Syndrome (AIDS)</D><P>Treatment of PCP associated with AIDS </P><D>The Upjohn Co., 7000 Portage Rd., Kalamazoo, MI 49001.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_clofazimine<P/><T3>Trade</T3>_Lamprene*/** <D>Treatment of lepromatous leprosy, including dapsone-resistant lepomatousleprosy and lepromatous leprosy complicated by erythema nodosum leprosum</D><D>Ciba-Geigy Corporation, 556 Morris Ave., Summit, NJ 07901.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_colchicine<P/><T3>Trade</T3>_Not established <D>For use in arresting the progression of neurologic disability causedby chronic progressive multiple sclerosis (MS) </D><D>Pharmacontrol Corporation, P.O. Box 931, Englewood Cliffs, NJ 07632.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_coplymer 1 (COP 1)<P/><T3>Trade</T3>_Not established <D>Treatment of multiple sclerosis (MS) </D><D>TAG Pharmaceuticals, C/O Lemmon Co., Sellersville, PA 18960.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cromolyn sodium<P/><T3>Trade</T3>_Gastrocrom <D>Mastocytosis </D><D>Fisons Corporation, 2 Preston Court, Bedford, MA 01730.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cromolyn sodium 4% ophthalmic solution<P/><T3>Trade</T3>_Opticrom 4% Ophthalmic Solution <D>Treatment of vernal keratoconjunctivitis (VKC) </D><D>Fisons Corporation, 2 Preston Court, Bedford, MA 01730.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cyclosporine ophthalmic<P/><T3>Trade</T3>_Optimmune <D>Treatment of severe keratoconjunctivitis sicca </D><D>University of GA Research Foundation, College of Veterinary Medicine,University of GA, Athens, GA 30602.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cyproterone acetate<P/><T3>Trade</T3>_Cyproteron/Androcur <D>Treatment of severe hirsutism </D><D>Berlex Laboratories, 110 East Hanover Avenue, Cedar Knolls, NJ 07927.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_cysteamine (2-aminoethanethiol)<P/><T3>Trade</T3>_Not established <D>Treatment of nephropathic cystinosis </D><D>Jess G. Thoene, M.D., Section of Biochemical Genetics and Metabolism,Dept. of Pediatrics, University of Michigan School of Medicine, Ann Arbor,MI 48109.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_dantrolene sodium<P/><T3>Trade</T3>_Dantrium <D>Treatment of neuroleptic malignant syndrome </D><D>Norwich Eaton Pharmaceuticals, P.O. Box 191, Norwich, NY 13815.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_defibrotide<P/><T3>Trade</T3>_Not established <D>Treatment of thrombotic thrombocytopenic purpura </D><D>Crinos International, Via Belvedere 1, 22079 Villa Guardia (Como), Italy.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_dextran sulfate sodium (UA001)<P/><T3>Trade_</T3>Not established<D>Treatment of Acquired Immunodeficiency Syndrome (AIDS)</D><D>Ueno Fine Chemicals Industry, Ltd., 2-31 Koraibashi, Higashi-Ku, Osaka541, Japan.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_diaziquone<P/><T3>Trade_</T3>Not established<D>Treatment of primary brain malignancies (Grade III-IV astrocytomas)</D><D>Warner-Lambert, 201 Tabor Rd., Morris Plains, NJ 07950.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_diethyldithiocarbamate<P/><T3>Trade_</T3>Imuthiol<D>Treatment of Acquired Immunodeficiency Syndrome (AIDS)</D><D>Merieux Institute, Inc., 7855 N.W. 12th St., Suite 114, Miami, Florida33126.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_dimethyl sulfoxide (DMSO)<P/><T3>Trade_</T3>Sclerosol<D>Treatment of cutaneous manifestations of scleroderma</D><D>Research Medical, Inc., A Subsidiary of Research Industries Corporation,1874 West 2300 South, Salt Lake City, UT 84119.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_dipalmitoylphosphatidylcholine (DPPC)/phosphatidylglycerol(PG)<P/><T3>Trade_</T3>ALEC (Artificial Lung Expanding Compound)<D>Prevention andamp; treatment of neonatal respiratory distress syndrome(RDS)</D><D>Britannia Pharmaceuticals, Ltd., Forum House, Brighton Road, Redhill,Surrey RH1 6YS, U.K.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_disodium silibinim dihemisuccinate<P/><T3>Trade_</T3>Legalon<D>Treatment of hepatic intoxication by Amanita phalloides (mushroom poisoning)</D><D>Pharmaquest Corporation, 201 Tamal Vista Blvd., Corte Madera, CA 94925;and </D><P>Dr. Madaus GmbH and Co., Ostmerheimer St., 198, 5000 Koln 91, FederalRepublic of Germany.</P></ITAG><ITAG tagnum="1"><T3>Generic</T3>_d,l-sotalol HCl<P/><T3>Trade_</T3>Not established<D>Treatment of life threatening ventricular tachyarrhythmias</D><P>Prevention of life threatening ventricular tachyarrhythmias</P><D>Bristol-Myers, Co., Pharmaceutical Research and Development Division,5 Research Pkwy., P.O. Box 5100, Wallingford, CT 06492-7660.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_eflornithine HCl (DFMO)<P/><T3>Trade_</T3>Ornidyl<D>Trypanosoma brucei gambiense sleeping sickness </D><P>Treatment of Pneumocystis carinii pneumonia (PCP) in Acquired ImmunodeficiencySyndrome (AIDS) patients</P><D>Merrell Dow Research, P.O. Box 6300, 2110 East Galbraith Road, Cincinnati,OH 45215-6300.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_epidermal growth factor (human)<P/><T3>Trade_</T3>Not established<D>Acceleration of corneal epithelial regeneration and healing of stromalincisions from corneal transplant surgery </D><P>Acceleration of corneal epithelial regeneration and the healing of stromaltissue in the condition of non-healing corneal defects</P><D>Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_epidermal growth factor (human)<P/><T3>Trade_</T3>Not established<D>Promotion of cutaneous wound healing in extreme burn treatment protocols</D><D>Ethicon, Inc., Somerville, NJ 08876-0151.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_epoprostenol prostacycline, PGI<T2>2</T2> PGX<P/><T3>Trade_</T3>Flolan<D>Replacement of heparin in patients requiring hemodialysis and who areat increased risk of hemorrhage</D><D>Burroughs-Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_epoprostenol<P/><T3>Trade_</T3>Cyclo-Prostin<D>Replacement of heparin in patients requiring hemodialysis and who areat increased risk of hemorrhage</D><D>The Upjohn Co., 301 Henrietta St., Kalamazoo, MI 49001.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_epoprostenol, prostacycline, PGI<T2>2</T2>, PGX<P/><T3>Trade_</T3>Flolan<D>Treatment of primary pulmonary hypertension (PPH)</D><D>Burroughs-Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_etidronate disodium<P/><T3>Trade_</T3>Didronel*/**<D>Treatment of hypercalcemia of a malignancy managed by dietary modificationand/or oral hydration</D><D>Norwich Eaton Pharmaceuticals, P.O. Box 191, Norwich, NY 13815.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_ethanolamine oleate<P/><T3>Trade_</T3>Ethamolin*/**<D>Treatment of patients with esophageal varices that have recently bled,to prevent rebleeding</D><D>Glaxo, Inc., P.O. Box 13960, Five Moore Drive, Research Triangle Park,NC 27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_ethinyl estradiol <P/><T3>Trade_</T3>Not established<D>Treatment of Turner's syndrome</D><D>Gynex, Inc., 570 Lake Cook Rd., Deerfield, IL 60015. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>fludarabine monophosphate <P/><T3>Trade_</T3>Not established <D>Treatment of chronic lymphocytic leukemia (CLL) </D><D>Triton Biosciences, 1501 Harbor Bay Pkwy., Alameda, CA 94501. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>flumecinol <P/><T3>Trade_</T3>Zixoryn <D>Hyperbilirubinemia in newborn infants unresponsive to phototherapy </D><D>Farmacon, Inc., P.O. Box 586, Westport, CT 06881. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>flunarizine <P/><T3>Trade_</T3>Sibelium <D>Treatment of alternating hemiplegia </D><D>Janssen Pharmaceuticals, 40 Kingsbridge Rd., Piscataway, NJ 08854. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>gallium nitrate <P/><T3>Trade_</T3>Not established <D>Treatment of hypercalcemia of malignancy </D><D>Lyphomed, Inc., 2020 Ruby St., Melrose Park, IL 60160. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>ganciclovir (DHPG) <P/><T3>Trade_</T3>Not established <D>Treatment of cytomegalovirus (CMV) infections of a serious life- orsight-threatening nature in immunocompromised patients </D><D>Syntex (USA), Inc., 3401 Hillview Ave., Palo Alto, CA 94304. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>gangliosides as sodium salts <P/><T3>Trade_</T3>Cronassial <D>Treatment of Retinitis Pigmentosa </D><D>Fidia Pharmaceutical, 1775 K St., NW., Suite 800, Washington, DC 20006.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>glucocerebrosidase/beta-glucosidase (placenta-derived)<P/><T3>Trade_</T3>Not established <D>Replacement therapy in patients with Gaucher's Disease Type I </D><D>Genzyme Corporation, 75 Kneeland St., Boston, MA 02111. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>guanethidine monosulfate <P/><T3>Trade_</T3>Ismelin I.V. <D>Treatment of moderate to severe reflex sympathetic dystrophy and causalgia</D><D>Ciba-Geigy Corporation, 556 Morris Ave., Summit, NJ 07901. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>hexamethylmelamine <P/><T3>Trade_</T3>Hexastat <D>Treatment of advanced adenocarcinoma of the ovary </D><D>Ives Laboratories, 685 Third Ave., New York, NY 10017. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>histrelin <P/><T3>Trade_</T3>Not established <D>Treatment of central precocious puberty </D><D>Ortho Pharmaceutical Corporation, Route 202, P.O. Box 300, Raritan,NJ 08869-0602. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>HPA-23 <P/><T3>Trade_</T3>Not established <D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><D>Rhone-Poulenc Pharmaceuticals, P.O. Box 125, Black Horse Lane, MonmouthJunction, NJ 08852. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>hydroxycobalamin/sodium thiosulfate <P/><T3>Trade_</T3>Not established <D>Treatment of severe acute cyanide poisoning </D><D>Evreka, Inc., P.O. Box 1513, 1990 Broadway, New York, NY 10023. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>idarubicin HCl <P/><T3>Trade_</T3>Not established <D>Treatment of acute myelogenous leukemia (AML), also referred to as acutenonlymphocytic leukemia (ANLL) </D><D>Adria Laboratories, 7001 Post Road, Dublin, Ohio 43216-6529. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>Iodine I 131 meta-iodobenzylguanidine <P/><T3>Trade_</T3>Not established <D>Diagnostic adjunct in patients with pheochromocytoma </D><D>William Beierwaltes, M.D., Nuclear Medicine, University of Michigan,Medical Center, 1405 E. Ann St., Ann Arbor, MI 48109. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>Iodine I 131 6B-iodomethyl-19-norcholesterol <P/><T3>Trade_</T3>Not established <D>Adrenal cortical imaging </D><D>William Beierwaltes, M.D., Nuclear Medicine, University of Michigan,Medical Center, 1405 E. Ann St., Ann Arbor, MI 48109. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>ifosfamide<P/><T3>Trade_</T3>Ifex*/**<D>Treatment of soft tissue sarcoma </D><P>Treatment of bone sarcoma </P><P>To be used in combination with other approved antineoplastic agents,for third line chemotherapy of germ cell testicular cancer. It should beused in combination with a prophylactic agent for hemorrhagic cystitis,such as mesna*/**</P><D>Bristol-Myers Co., P.O. Box 4755, Syracuse, NY, 13221-4755. </D><P>Bristol-Myers Co., Pharmaceutical Research and Development Division,Wallington, CT 06492. </P></ITAG><ITAG tagnum="1"><T3>Generic</T3>_inosine pranobex <P/><T3>Trade</T3>_Isoprinosine<D>Treatment of subacute sclerosing panencephalitis</D><D>Newport Pharmaceuticals, Inc., 897 W. Sixteenth St., Newport Beach,CA 92663. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_l-alpha-acetylmethadol (LAAM) <P/><T3>Trade</T3>_Not established<D>Treatment of heroin addicts suitable for maintenance on opiate agonists</D><D>Dixon and Williams Pharmaceutical Co., 43 Old Wood Road, Bernardsville,NJ 07924. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_l-carnitine <P/><T3>Trade</T3>_Vita Carn*<D>Genetic carnitine deficiency*</D><D>Kendall McGaw Laboratories, P.O. Box 25080, Santa Ana, CA 92799-5080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_l-carnitine <P/><T3>Trade</T3>_Vita Carn <D>Treatment of manifestations of carnitine deficiency in patients withend stage renal disease (ESRD) who require dialysis </D><D>Kendall McGaw Laboratories, P.O. Box 25080, Santa Ana, CA 92799-5080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_l-carnitine <P/><T3>Trade</T3>_Carnitor*/** <D>Primary and secondary carnitine deficiency of genetic origin*/** </D><P>Treatment of manifestations of carnitine deficiency in patients withend stage renal disease (ESRD) who require dialysis </P><D>Sigma Tau, Inc., 723 North Beers St., Holmdel, NJ 07733.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_leucovorin calcium <P/><T3>Trade</T3>_Wellcovorin <D>Treatment of metastatic colorectal cancer </D><D>Burroughs Wellcome Co., 3030 Cornwallis Road, Research Triangle Park,NC 27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_leucovorin calcium <P/><T3>Trade</T3>_Leucovorin*/** <D>For use in combination with 5-fluorouracil for the therapy of metastaticadenocarcinoma of the colon and rectum </D><P>For rescue use after high dose methotrexate therapy in the treatmentof osteosarcoma*/** </P><D>Lederle Laboratories, Pearl River, NY 10965.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_leuprolide acetate <P/><T3>Trade</T3>_Lupron Injection <D>Treatment of central precocious puberty </D><D>TAP Pharmaceuticals, D-49N, 1400 N. Sheridan Rd., Abbott Park, IL 60064.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_levocabastine HCl <P/><T3>Trade</T3>_Not established <D>Treatment of vernal keratoconjunctivitis (VKC) </D><D>Iolab Pharmaceuticals, 500 Iolab Drive, Claremont, CA 91711.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_LHRH [(DES-GLY\1\\0\)-D-Trp\6\-Pro\9\-N-Ethylamide)] <P/><T3>Trade</T3>_Not established <D>Treatment of central precocious puberty </D><D>Roberts Laboratories, Meridian Center III, 6 Industrial Way West, Eatontown,NJ 07724.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_L-Leucine, L-isoleucine and L-valine <P/><T3>Trade</T3>_Not established <D>Treatment of amyotrophic lateral sclerosis (ALS) </D><D>Andreas Plaitakis, M.D., The Mount Sinai Medical Center, Departmentof Neurology, One Gustave Levy Pl., New York, NY 10029.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_l-5 hydroxytryptophan (L-5HTP) <P/><T3>Trade</T3>_Not established <D>Treatment of postanoxic intention myoclonus </D><D>Bolar Pharmaceuticals, 130 Lincoln Street, Copiague, NY 11726.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_luteinizing hormone releasing hormone (GnRH) <P/><T3>Trade</T3>_Not established <D>Induction of ovulation in women with hypothalamic amenorrhea due toa deficiency or absence in the quantity or pulse pattern of endogenousGnRH secretion </D><D>Ortho Pharmaceuticals, Route 202, P.O. Box 300, Raritan, NJ 08869-0602.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_mazindol <P/><T3>Trade</T3>_Sanorex <D>Treatment of Duchenne muscular dystrophy (DMD) </D><D>Platon J. Collip, M.D., 176 Memorial Dr., Jesup, GA 31545.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_mefloquine HCl <P/><T3>Trade</T3>_Mephaquin <D>Treatment of chloroquine-resistant falciparum malaria </D><P>Prevention of chloroquine-resistant falciparum malaria </P><D>Mephra AG, 4143 Dornach, Aesch Basel, Switzerland.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_mefloquine HCl <P/><T3>Trade</T3>_Lariam <D>Treatment of acute malaria due to Plasmodium falciparum and plasmodiumvivax </D><P>Prophylaxis of Plasmodium falciparum malaria which is resistant to otheravailable drugs </P><D>Hoffmann-La Roche Inc., 340 Kingsland St., Nutley, NJ 07110.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_megestrol acetate <P/><T3>Trade</T3>_Megace <D>Treatment of patients with anorexia, cachexia, or significant weightloss (=/andgreater; 10% of baseline body weight) and confirmed diagnosisof AIDS </D><D>Bristol-Myers U.S. Pharmaceutical andamp; Nutritional Group, 2404 PennsylvaniaStreet, Evansville, IN 47721-0001.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_mesna <P/><T3>Trade</T3>_Mesnex*/** <D>For use as a prophylactic agent in reducing the incidence of ifosfamide-inducedhemorrhagic cystitis </D><D>Degussa Corporation, P.O. Box 2004, Route 46 at Hollister Rd., Teterboro,NJ 07608.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_mesna <P/><T3>Trade</T3>_Not established <D>Inhibition of the uro-toxic effects induced by oxazaphosphorine compoundssuch as cyclophosphamide </D><D>Adria Laboratories, P.O. Box 16529, Columbus, OH 43216-6529.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_methotrexate sodium <P/><T3>Trade</T3>_Methotrexate*/**<D>For use with leucovorin rescue in combination with other chemotherapeuticagents to delay recurrence in patients with non-metastatic osteosarcomawho have undergone surgical resection or amputation for the primary tumor</D><D>Lederle Laboratories, Pearle River, NY 10965. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_metronidazole (topical)<P/><T3>Trade</T3>_MetroGel*/** <D>Treatment of acne rosacea </D><D>Curatek Pharmaceuticals, 1965 Pratt Blvd., Elk Grove Village, IL 60007.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_metronidazole (tropical)<P/><T3>Trade</T3>_Flagyl<D>Treatment of Grade III and IV, anaerobically infected, decubitus ulcers</D><D>G.D. Searle and Co., Box 5110, Chicago, IL 60680.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_midodrine HCl<P/><T3>Trade</T3>_Amatine <D>Treatment of idiopathic orthostatic hypotension </D><D>Roberts Laboratories, 230 Half Mile Rd., Red Bank, NJ 07701. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_mitoxantrone HCl<P/><T3>Trade</T3>_Novantrone*/** <D>Treatment of acute myelogenous leukemia (AML), also referred to as acutenonlymphocytic leukemia (ANLL) </D><D>Lederle Laboratories, Pearl River, NY 10965. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_monooctanoin<P/><T3>Trade</T3>_Moctanin*/** <D>Dissolution of cholesterol gallstones retained in the common bile duct</D><D>Ethitek Pharmaceuticals, 8100 North Lawndale Ave., Skokie, IL 60076.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_morphine sulfate concentrate (preservative free)<P/><T3>Trade</T3>_Duramorph <D>For administration via microinfusion devices in repeated doses or constantinfusion, for </D><T3>epidural</T3> use in the treatment of severe chronic pain which respondsinadequately to systemic analgesic therapy or when epidural administrationis considered preferable to systemic administration and for <T3>intrathecal</T3> use in patients with refractory pain due to malignancy<D>Elkins-Sinn, Inc., 2 Esterbrook Lane, Cherry Hill, NJ 08003-4099. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_nafarelin acetate<P/><T3>Trade</T3>_None established <D>Treatment of central precocious puberty </D><D>Syntex (U.S.A.) Inc., 3401 Hillview Avenue, P.O. Box 10850, Palo Alto,CA 94303. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_naltrexone HCl<P/><T3>Trade</T3>_Trexan*/** <D>Blockade of the pharmacological effects of exogenously administeredopioids as an adjunct to the maintenance of the opioid-free state in detoxifiedformerly opioid-dependent individuals </D><D>E.I. du Pont de Nemours, dba Du Pont Pharmaceuticals, 1000 Stewart Ave.,Garden City, NY 11530. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_oxymorphone HCl <P/><T3>Trade</T3>_Numorphan H.P <D>Relief of severe intractable pain in narcotic-tolerant patients </D><D>Du Pont Pharmaceuticals, P.O. Box 12, Manati, Puerto Rico 00701. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_PEG-adenosine deaminase (PEG-ADA)<P/><T3>Trade</T3>_Imudon <D>Enzyme replacement therapy for ADA deficiency in patients with severecombined immunodeficiency disease (SCID) </D><D>Enzon, Inc., 300C Corporate Court, South Plainfield, NJ 07080. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_pentamidine isethionate (Injectable)<P/><T3>Trade</T3>_Pentam 300*/** <D>Treatment of Pneumocystis carinii pneumonia (PCP)*/** </D><D>LyphoMed, Inc., 2020 Ruby Street, Melrose Park, IL 60160. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_pentamidine isethionate (Injectable)<P/><T3>Trade</T3>_Not established <D>Treatment of Pneumocystis carinii pneumonia (PCP) </D><D>Rhone-Poulenc, 52 Vanderbilt Ave., New York, NY 10017. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>pentamidine isethionate (inhalation) <P/><T3>Trade_</T3>Pneumopent <D>Prevention of Pneumocystis carinii pneumonia (PCP) in patients at highrisk of developing this disease </D><D>Fisons Corporation, 2 Preston Cort, Bedford, MA 01730. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>pentamidine isethionate (inhalation) <P/><T3>Trade_</T3>Pentam 300 <D>Prevention of Pneumocystis carinii pneumonia (PCP) in patients at highrisk of developing this disease </D><D>LyphoMed, Inc., 2020 Ruby Street, Melrose Park, IL 60160. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>pentostatin <P/><T3>Trade_</T3>Not established <D>Treatment of Hairy Cell Leukemia </D><D>Warner-Lambert, 2800 Plymouth Rd., P.O. Box 1047, Ann Arbor, MI 48106.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>phosphocysteamine <P/><T3>Trade_</T3>Not established <D>Treatment of cystinosis </D><D>Medea Research Laboratories, Suffolk Co. Airport, Building 32, WesthamptonBeach, N.Y. 11978. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>physostigmine salicylate <P/><T3>Trade_</T3>Antilirium <D>Friedreich's and other inherited ataxias </D><D>Forrest Pharmaceuticals, 2510 Metro Blvd., Maryland Heights, MO 64043-9979.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>piracetam <P/><T3>Trade_</T3>Nootropil <D>Treatment of myoclonus </D><D>U.C.B. Secteur Pharmaceutique, 326 Ave. Louise, 105 Brussels, Belgium.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>piritrexim isethionate <P/><T3>Trade_</T3>Not established <D>Treatment of infections caused by Pneumocystis carinii, Toxoplasma gondii,and Mycobacterium avium-intracellulare </D><D>Burroughs Wellcome, 3030 Cornwallis Rd., Research Triangle Park, N.C.27709. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>potassium citrate <P/><T3>Trade_</T3>Urocit-K*/** <D>Prevention of calcium renal stones in patients with hypocitraturia </D><P>Avoidance of the complication of calcium stone formation in patientswith uric acid lithiasis </P><P>Prevention of uric acid nephrolithiasis </P><D>Charles Y.C. Pak, M.D., University of Texas Health Science Center atDallas, 5323 Harry Hines Blvd., Dallas, TX 75235. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>potassium citrate and citric acid <P/><T3>Trade_</T3>Polycitra-K <D>Dissolution and control of uric acid and cystine calculi in the urinarytract </D><D>Willen Drug Co., 18 North High St., Baltimore, MD 21202. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>praziquantel <P/><T3>Trade_</T3>Cysticide <D>Treatment of neurocysticercosis </D><D>EM Pharmaceuticals, 5 Skyline Drive, Hawthrone, NY 10532. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>prednimustine <P/><T3>Trade_</T3>Sterecyt <D>Treatment of malignant non-Hodgkin's lymphomas </D><D>Pharmacia, Inc., 800 Centennial Ave., Picataway, NJ 08855. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>propamidine isethionate (0.1%) <P/><T3>Trade_</T3>Brolene Eye Drops <D>Treatment of Acanthamoeba keratitis </D><D>Bausch andamp; Lomb, Inc., 1400 North Goodman Street, Rochester, NY 14692-0450.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>protirelin (TRH) <P/><T3>Trade_</T3>Thymone <D>Amyotrophic lateral sclerosis (ALS) </D><D>Abbott Laboratories, North Chicago, IL 60064. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>pulmonary surfactant replacement <P/><T3>Trade_</T3>Not established <D>Prevention and treatment of respiratory distress syndrome (RDS) </D><D>California Biotechnology, 2450 Bayshore Pkwy., Mountain View, CA 94043.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>quinacrine HCl <P/><T3>Trade_</T3>Not established <D>Prevention of recurrence of pneumothorax in patients at high risk ofrecurrence, e.g., patients with cystic fibrosis </D><D>LyphoMed, Inc., 2020 Ruby Street, Melrose Park, IL 60160. </D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>rifampin <P/><T3>Trade_</T3>Rifadin I.V. <D>Antituberculosis treatment where use of the oral form of the drug isnot feasible </D><D>Merrell Dow Research Inst., 2110 E. Galbraith, Cincinnati, OH 45215.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>rifampin, isoniazid, pyrazinamide <P/><T3>Trade_</T3>Rifater <D>Short course treatment of tuberculosis </D><D>Merrell Dow Research Inst., 2110 E. Gailbraith, Cincinnati, OH 45215.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>selegiline HCl <P/><T3>Trade_</T3>Deprenyl <D>Adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson'sdisease (paralysis agitans), postencephalitic parkinsonism, and symptomaticparkinsonism </D><D>Somerset Pharmaceuticals, One Olde Town Court, Bernardsville, NJ 07924.</D></ITAG><ITAG tagnum="1"><T3>Generic_</T3>sermorelin acetate [GRF(1-29)NH2] <P/><T3>Trade_</T3>Not established <D>Treatment of idiopathic and organic growth hormone deficiency in childrenwith growth failure </D><D>Serono Laboratories, 280 Pond Street, Randolph, MA 02368. </D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_sodium monomercaptoundecahydro-closo-dodecaborate <P/><T3>Trade</T3>_Borolife<D>Treatment of glioblastoma multiforme as an alternative to conventionalphoton therapy</D><D>Theragenics Corporation, 900 Atlantic Drive, Atlanta, GA 30318.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_sodium oxybate (gammahydroxybutyrate) <P/><T3>Trade</T3>_Not established<D>Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleepparalysis, hypnagogic hallucinations and automatic behavior</D><D>Sigma Fandamp;D Div. of Sigma Chemical Co., 3050 Spruce St., St. Louis,MO 63103.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_sodium oxybate (gammahydroxybutyrate)<P/><T3>Trade</T3>_Not established<D>Treatment of narcolepsy and the auxiliary symptoms of cataplexy, sleepparalysis, hypnagogic hallucinations and automatic behavior</D><D>Biocraft Laboratories, 92 Route 46, Elmwood Park, NJ 07407.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_sodium pentosan polysulphate<P/><T3>Trade</T3>_Elmiron<D>Treatment of interstitial cystitis</D><D>Medical Market Specialties, P.O. Box 150, Boonton, NJ 07005.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_sodium tetradecyl sulfate<P/><T3>Trade</T3>_Sotradecol<D>Treatment of bleeding esophageal varices</D><D>Elkins-Sinn, 2 Esterbrook La., Cherry Hill, NJ 08003-4099.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatostatin<P/><T3>Trade</T3>_Reducin<D>Adjunct to the non-operative management of secreting cutaneous fistulasof the stomach, duodenum, small intestine (jejunum and ileum), or pancreas</D><D>Ferring Laboratories, Montebello Park, 75 Montebello Rd., Suffern, NY10901.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatrem<P/><T3>Trade</T3>-Protropin */**<D>Long-term treatment of children who have growth failure due to a lackof adequate endogenous growth hormone secretion</D><D>Genentech, Inc., 460 Point San Bruno Blvd., South San Francisco, CA94080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatrem<P/><T3>Trade</T3>_Protropin<D>Short stature associated with Turner's syndrome</D><D>Genentech, Inc., 460 Point San Bruno Blvd., South San Francisco, CA94080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatropin<P/><T3>Trade</T3>_Humatrope */**<D>Long-term treatment of children who have growth failure due to inadequatesecretion of normal endogenous growth hormone</D><D>Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatropin<P/><T3>Trade</T3>_Saizen<D>Treatment of idiopathic or organic growth hormone deficiency in childrenwith growth failure</D><D>Serono Laboratories, 280 Pond Street, Randolph, MA 02368.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatropin<P/><T3>Trade</T3>_Protropin II<D>Long-term treatment of children who have growth failure due to a lackof adequate endogenous growth hormone secretion</D><D>Genentech, Inc., 460 Point San Bruno Blvd., South San Francisco, CA94080.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_somatropin<P/><T3>Trade</T3>_Norditropin<D>Treatment of growth failure in children due to inadequate growth hormonesecretion </D><P>For adjunctive use in the induction of ovulation in women with infertilitydue to 1) hypogonadotropic hypogonadism, and 2) bilateral tubal occlusionor unexplained infertility, who are undergoing in-vivo fertilization proceduresor in-vitro fertilization with embryo transfer procedures, respectively,and who fail to ovulate in response to gonadotropin therapy alone</P><P>Treatment of short stature associated with Turner's Syndrome</P><D>Nordisk-USA, 3202 Monroe St., Suite 100, Rockville, MD 20852.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_spiramycin<P/><T3>Trade</T3>_Rovamycine<D>Symptomatic relief and parasitic cure of chronic cryptosporidiosis inpatients with immunodeficiency</D><D>Rhone-Poulenc, Inc., 52 Vanderbilt Ave., New York, NY 10017.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_superoxide dismutase (recombinant/human)<P/><T3>Trade</T3>_Not established<D>Protection of donor organ tissue from damage or injury mediated by oxygen-derivedfree radicals that are generated during the necessary periods of ischemia(hypoxia, anoxia), and especially reperfusion, associated with the operativeprocedure </D><D>Pharmacia-Chiron Partnership, 4560 Horton Street, Emeryville, CA 94608.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_superoxide dismutase (recombinant/human)<P/><T3>Trade</T3>_Not established<D>Prevention of reperfusion injury to donor organ tissue</D><D>Bristol-Myers Co., 5 Research Pkwy., Wallingford, CT 06492.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_surface active extract of saline lavage of bovine lungs<P/><T3>Trade</T3>_Infasurf<D>Treatment and prevention of respiratory failure due to pulmonary surfactantdeficiency in preterm infants</D><D>Ony, Inc., TDC Incubation Center, 2211 Main Street, Buffalo, NY 14214.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_surfactant (human) (amniotic fluid derived)<P/><T3>Trade</T3>_Human Surf<D>Prevention and treatment of neonatal respiratory distress syndrome (RDS)</D><D>T. Allen Merritt, M.D., University of California San Diego Medical Center,225 W. Dickinson Street, H-814-J, San Diego, CA 92103.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_surfactant TA (modified bovine lung surfactant extract)<P/><T3>Trade</T3>_Survanta<D>Prevention and treatment of neonatal respiratory distress syndrome (RDS)</D><D>Ross Laboratories, 625 Cleveland Ave., Columbus, OH 43216.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_teniposide (VM-26)<P/><T3>Trade</T3>_Not established<D>Treatment of refractory childhood acute lymphocytic leukemia (ALL)</D><D>Bristol-Myers Pharmaceutical Research andamp; Development Div., P.O. Box4755, Syracuse, NY 13221-4755.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_teriparatide<P/><T3>Trade</T3>_Parathar*/**<D>Diagnostic agent to assist in establishing the diagnosis in patientspresenting with clinical and laboratory evidence of hypocalcemia due toeither hypoparathyroidism or pseudohypoparathyroidism</D><D>Rorer Pharmaceuticals, Fort Washington, PA 19034.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_terlipressin<P/><T3>Trade</T3>_Glypressin<D>Treatment of bleeding esophageal varices</D><D>Ferring AB, Soldattorspvagen 5, Box 30651, 200 62 Malmo, Sweden.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_thalidomide<P/><T3>Trade</T3>_Not established<D>Treatment of graft versus host disease (GVHD) in patients receivingbone marrow transplantation (BMT)</D><P>Prevention of GVHD in patients receiving BMT</P><P>Treatment and maintenance of reactional lepromatous leprosy</P><D>Pediatric Pharmaceuticals, 379 Thornall St., Edison, NJ 08837.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_thymoxamine HCl<P/><T3>Trade</T3>_Not established<D>Reversal of phenylephrine-induced mydriasis in patients who have narrowanterior angles and are at risk of developing an acute attack of angle-closureglaucoma following mydriasis</D><D>Iolab Pharmaceuticals, 500 Iolab Drive, Claremont, CA 91711.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_tiopronin<P/><T3>Trade</T3>_Thiola*/**<D>Prevention of cystine nephrolithiasis in patients with homozygous cystinuria</D><D>Charles Y.C. Pak, M.D., The University of Texas Health Science Centerat Dallas, 5323 Harry Hines Blvd., Dallas, TX 75235.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_tocophersolan oral solution [(Vitamin E, d-alpha tocopherylpolylene glycol-1000 succinate (TPGS)<P/><T3>Trade</T3>_Not established<D>Treatment of Vitamin E deficiency resulting from malabsorption due toprolonged cholestatic hepatobiliary disease</D><D>Eastman Pharmaceuticals, 2260 Lake Avenue, Rochester, NY 14650.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_tranexamic acid<P/><T3>Trade</T3>_Cyklokapron<D>Treatment of hereditary angioneurotic edema</D><P>Treatment of patients undergoing prostatectomy where there is hemorrhageor risk of hemorrhage as a result of increased fibrinolysis or fibrinogenolysis</P><D>Kabi Vitrum, 1311 Harbor Bay Pkwy., Alameda, CA 94501.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_tranexamic acid<P/><T3>Trade</T3>_Cyklokapron*/**<D>Treatment of patients with congenital coagulopathies who are undergoingsurgical procedures e.g. dental extractions</D><D>Kabi Vitrum, 1311 Harbor Bay Pkwy., Alameda, CA 94501.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_tretinoin<P/><T3>Trade</T3>_Not established<D>Treatment of squamous metaplasia of the ocular surface epithelia (conjunctivaand/or cornea) with mucous deficiency and keratinization</D><D>Spectra Pharmaceutical Services, Hanover Business Park, 155 WebsterStreet, Hanover, MA 02339.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_trientine HCl<P/><T3>Trade</T3>_Cuprid*/**<D>Treatment of patients with Wilson's disease who are intolerant, or inadequatelyresponsive to penicillamine</D><D>Merck Sharp andamp; Dohme, Research Laboratories, West Point, PA 19486.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_trimetrexate glucuronate<P/><T3>Trade</T3>_Not established<D>Treatment of metastatic colorectal adenocarcinoma</D><P>Treatment of metastatic carcinoma of the head and neck (i.e. buccalcavity, pharynx and larynx) </P><P>Treatment of pancreatic adenocarcinoma </P><P>Treatment of Pneumocystis carinii pneumonia (PCP) in AIDS patients </P><P>Treatment of patients with advanced nonsmall cell carcinoma of the lung</P><D>Warner-Lambert, 2800 Plymouth Rd., P.O. Box 1047, Ann Arbor, MI 48106.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_urofollitropin<P/><T3>Trade</T3>_Metrodin*/**<D>Induction of ovulation in patients with polycystic ovarian disease whohave an elevated LH/FSH ratio and who have failed to respond to adequateclomiphene citrate therapy</D><D>Serono Laboratories, 280 Pond Street, Randolph, MA 02368.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_viloxazine HCl<P/><T3>Trade</T3>_Vivalan<D>Treatment of narcolepsy </D><P>Treatment of cataplexy</P><D>Stuart Pharmaceuticals, Wilmington, DE 19897.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_zidovudine (AZT)<P/><T3>Trade</T3>_Retrovir*/**<D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><P>Treatment of certain patients with AIDS Related Complex (ARC)</P><D>Burroughs Wellcome, 3030 Cornwallis Rd., Research Triangle Park, NC27709.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_zinc acetate<P/><T3>Trade</T3>_Not established<D>Treatment of Wilson's disease</D><D>Lemmon Co., 650 Cathill Rd., Sellerville, PA 18960.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_4-aminopyridine (4-AP)<P/><T3>Trade</T3>_Not established <D>Relief of symptoms of multiple sclerosis (MS) </D><D>Rush-Presbyterian-St. Lukes Medical Center, 1753 West Congress Pkwy.,Chicago, IL 60612.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_5-AZA-2andmin16;-deoxycytidine (DAC)<P/><T3>Trade</T3>_Not established <D>Treatment of acute leukemia </D><D>Pharmachemie B.V., Nijverheidsweg 48-50, P.O. Box 552, 2003 RN Haarlem,Holland.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_4-methylpyrazole<P/><T3>Trade</T3>_4-MP <D>Treatment of methanol, ethylene glycol, 2-methoxyethanol or 2-butoxyethanolpoisoning </D><D>Kenneth E. McMartin, Louisiana State University Medical Center, Departmentof Pharmacology, P.O. Box 33932, Shreveport, LA 71130-3932.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_2andmin16;-3andmin16;-dideoxyadenosine<P/><T3>Trade</T3>_Not established <D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><D>National Cancer Inst., Bldg. 31, Room 3A49, NIH, Bethesda, MD 20892.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_2andmin16;-3andmin16;-dideoxycytidine<P/><T3>Trade</T3>_Not established <D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><D>Hoffmann-La Roche, 340 Kingsland St., Nutley, NJ 07110.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_2andmin16;-3andmin16;-dideoxycytidine<P/><T3>Trade</T3>_Not established <D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><D>National Cancer Inst., Bldg. 31, Room 3A49, NIH, Bethesda, MD 20892.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_2andmin16;-3andmin16;-dideoxyinosine<P/><T3>Trade</T3>_Not established <D>Treatment of Acquired Immunodeficiency Syndrome (AIDS) </D><D>Bristol-Myers Co., 5 Research Pkwy., P.O. Box 5100, Wallingford, CT06492-7660.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_2,3-dimercaptosuccinic Acid (DMSA)<P/><T3>Trade</T3>_Not established <D>Treatment of lead poisoning in children </D><D>Johnson and Johnson Baby Products Co., Grandview Road, Skillman, NJ08858.</D></ITAG><ITAG tagnum="1"><T3>Generic</T3>_24,25 dihydroxycholecalciferol<P/><T3>Trade</T3>_Not established <D>Treatment of uremic osteodystrophy </D><D>Lemmon Co/TAG Pharmaceuticals, P.O. Box 630, Sellersville, PA 18960.</D></ITAG></ITAG><ITAG tagnum="40">[FR Doc. 89-6595 Filed 4-20-89; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4160-01-M </ITAG></ITAG></ITAG></TEXT></DOC>